SIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE IN OSTEOARTHRITIS

dc.contributor.author	Sobirova G.N., Saidrasulova G.B., Abdullaeva U.K., Bafoeva Z.O., Ashirova N.Z., Kurbanaliev X.X., Musakhanov A.K., Gaipov O.U.
dc.date.accessioned	2026-04-06T17:44:09Z
dc.date.available	2026-04-06T17:44:09Z
dc.date.issued	2025
dc.identifier.issn	2231-2218
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/3213
dc.description.abstract	Abstract. Osteoarthritis (OA) is a multifactorial, degenerative arthritis. Factors such as obesity, low-grade chronic inflammation, and insulin resistance are key factors in the development and pathogenesis of OA. In summary, OA has been observed to associate with a number of systemic diseases, including obesity, cardiovascular disease, type 2 diabetes, and metabolic syndrome. The importance of non-alcoholic fatty liver disease based on metabolic syndrome is studied in many scientific studies. Recently, scientific work has been carried out to study metabolicassociated fatty liver disease (MAFLD) and related diseases. In this scientific work, the importance of MAFLD in the course of OA is studied.	en_US
dc.language.iso	en	en_US
dc.publisher	Asian journal of Pharmaceutical and biological research	en_US
dc.subject	osteoarthritis; metabolic syndrome; MASLD; x-ray; VAS scale;	en_US
dc.title	SIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE IN OSTEOARTHRITIS	en_US
dc.type	Article	en_US